Also trades as: MDCXW (NASDAQ) · $vol 0M
MDCX NASDAQ
Medicus Pharma Ltd. Common Stock
1W: +5.6%
1M: -38.0%
3M: -65.0%
YTD: -89.9%
1Y: -92.8%
$0.16
+0.00 (+2.55%)
Weekly Expected Move ±7.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$10.2M
52W Range0.144-2.78
Volume1,000,937
Avg Volume3,883,086
Beta-0.61
Dividend—
Analyst Ratings
Company Info
CEORaza Bokhari
Employees16
SectorHealthcare
IndustryBiotechnology
IPO Date2024-11-15
Websitemedicuspharma.com
300 Conshohocken State Road
West Conshohocken, PA 19428
CA
West Conshohocken, PA 19428
CA
+1 416 861 1685
About Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
Latest News
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
Pfizer, Medicus ink licensing deal worth up to $1B for antibody drug conjugate
Quant Check: Top- and bottom-rated small-cap healthcare stocks post-earnings
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Smith Andrew Alasdai | A-Award | 735,294 | $0.17 | 2026-09-04 |
| Smith Andrew Alasdai | A-Award | 125,000 | $0.17 | 2026-09-04 |
| Mehmud Faisal | A-Award | 1,470,588 | $0.17 | 2026-09-04 |
| Mehmud Faisal | A-Award | 250,000 | $0.17 | 2026-09-04 |
| Brennan Edward J. | A-Award | 588,235 | $0.17 | 2026-09-04 |